Quantitative mRNA expression of genes involved in angiogenesis, coagulation and inflammation in multiforme glioblastoma tumoral tissue versus peritumoral brain tissue: Lack of correlation with clinical data

European Cytokine Network

Volumn 23, Issue 2, 2012, Pages 45-55

  Berindan Neagoe, Ioana ^a,b   Chiorean, Roxana ^c   Braicu, Cornelia ^a   Florian, Ioan Stefan ^b,d   Leucuta, Daniel ^b   Crisan, Doinita ^b   Cocis, Adriana ^c   Balacescu, Ovidiu ^a   Irimie, Alexandru ^a,b  

^a Cancer Institute Ion Chiricuta Cluj Napoca   (Romania)

^b IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c Clinical Universitary Hospital of Dermatovenereology   (Romania)

^d Department of Neurosurgery   (Romania)

Author keywords

Angiogenesis; Coagulation; Glioblastoma multiforme; Histopathology; Inflammation; RT PCR

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; ENDOTHELIAL PROTEIN C RECEPTOR; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR; TUMOR NECROSIS FACTOR; VASCULOTROPIN;

ADULT; ANGIOGENESIS; ARTICLE; BLOOD CLOTTING; BRAIN TISSUE; CARCINOGENESIS; CLINICAL ARTICLE; COAGULATION NECROSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GANGRENE; GENE EXPRESSION PROFILING; GENE FUNCTION; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERPLASIA; INFLAMMATION; MALE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE; TRANSCRIPTION REGULATION; TUMOR NECROSIS; TUMOR VASCULARIZATION;

ANTIGENS, CD; BLOOD COAGULATION; BRAIN; BRAIN NEOPLASMS; CONNECTIVE TISSUE GROWTH FACTOR; FEMALE; GLIOBLASTOMA; HUMANS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; MALE; NEOVASCULARIZATION, PATHOLOGIC; PLATELET-DERIVED GROWTH FACTOR; RECEPTORS, CELL SURFACE; RNA, MESSENGER; TUMOR NECROSIS FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84863860246     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: 10.1684/ecn.2012.0302     Document Type: Article

References (55)

1. Showalter TN, Andrel J, Andrews DW, Curran WJ Jr, Daskalakis C Werner-Wasik M. Multifocal Glioblastoma Multiforme: Prognostic Factors and Patterns of Progression. Int J Radiat Oncol Biol Phys 2007; 69(3):820-4.
2. Anderson JC, McFarland BC, Gladson CL. New molecular targets in angiogenic vessels of glioblastoma tumours. Expert Rev Mol Med 2008; 10:e23, doi: 10.1017/S1462399408000768.
3. Reynés G, Vila V, Martín M, et al. Circulating markers of angiogenesis, inflammation, and coagulation in patients with glioblastoma. J Neurooncol 2011; 102(1): 35-41.
4. Tatter SB. The new WHO Classification of Tumors affecting the Central Nervous System 2005; Accessed on 2009-08-12.
5. Chi AS, Sorensen AG, Jain RK, Batchelor TT. Angiogenesis as a therapeutic target in malignant gliomas. Oncologist 2009;14(6):621-36.
6. Weller M. Novel diagnostic and therapeutic approaches to malignant glioma. Swiss Med Wkly 2011; 141:w13210. doi: 10.4414/smw.2011.13210.
7. Walbert T, Mikkelsen T. Recurrent high-grade glioma: a diagnostic and therapeutic challenge. Expert Rev Neurother 2011; 11(4):509-18.
8. Wei J, Wu A, Kong LY. Hypoxia potentiates glioma-mediated immunosuppression. PLoS One 2011 6(1):e16195.
9. Kleihues P, Burger PC, Aldape KD, Brat DJ, BiernatW, BignerDD. Glioblastoma. In: Louis DN, Ohgaki H, Wiestler OD, CaveneeWK et al. (eds) WHO classification of tumors of the Central Nervous System, 4th edn. IARC, Lyon,2007, pp 33-49.
10. Nazarenko I, Hedrén A, Sjödin H, et al. Brain abnormalities and glioma-like lesions in mice overexpressing the long isoform of PDGF-A in astrocytic cells. PLoS One 7 2011; 6(4):e18303.
11. de Groot JF, Piao Y, Tran HT, Gilbert MR, et al. Myeloid Biomarkers Associated with Glioblastoma Response to Anti-Vascular Endothelial Growth Factor Therapy with Aflibercept. Clin Cancer Res 2001; 17(14):4872-4881.
12. Carlson M, Nakamura Y, Payson R, et al. Isolation and mapping of a polymorphic DNA sequence (pMCT108.2) on chromosome 18 [D18S24]. Nucleic Acids Res 1988; 16 (9):4188.
13. Ueda R, Kohanbash G, Sasaki K, et al. Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic Tlymphocytes by down-regulation of ICAM-1. Proc Natl Acad Sci USA 2009; 106(26):10746-51.
14. Kuppner MC, van Meir E, Hamou MF, de Tribolet N. Cytokine regulation of intercellular adhesion molecule-1 (ICAM-1) expression on human glioblastoma cells. Clin Exp Immunol 1990; 81(1): 142-8.
15. Kesanakurti D, Chetty C, Bhoopathi P, et al. Suppression of MMP-2 Attenuates TNF-_ Induced NF-_B Activation and Leads to JNK Mediated Cell Death in Glioma. PLoS One 2011;6(5):e19341.
16. Xie D, Yin D, Wang HJ, et al. Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas. Clin Cancer Res 2004; 10(6):2072-81.
17. Brigstock DR. Regulation of angiogenesis and endothelial cell function by connective tissue growth factor (CTGF) and cysteinerich 61 (CYR61). Angiogenesis 2002; 5:153-165.
18. Ivkovic S, Yoon BS, Popoff SN, et al. Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal deveopment. Development 2003; 130:2779-2791.
19. Inoki I, Shiomi T, Hashimoto G et al. Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis. FASEB J 2002; 16(2):219-21.
20. Nicolaes GA, Dahlbäck B. Congenital and acquired activated protein C resistance. Semin Vasc Med 2003; 3 (1): 33-46.
21. Mather T, Oganessyan V, Hof P. et al. The 2.8Å crystal structure of Gla-domainless activated protein C. EMBO J 1996; 15 (24): 6822-31.
22. Rong Y, Durden DL, Van Meir EG, Brat DJ. "Pseudopalisading" necrosis in glioblastoma: a familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis. J Neuropathol Exp Neurol 2006; 65(6):529-39.
23. Abdulrauf SI, Edvardsen K, Ho KL, YangXY, Rock JP, Rosenblum ML. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma. J Neurosurg. 1998; 88(3): 513-20.
24. Claes A, Idema AJ, Wesseling P. Diffuse glioma growth: a guerilla war. Acta Neuropathol 2007; 114(5):443-58.
25. Tehrani M, Friedman TM, Olson JJ, Brat DJ. Intravascular thrombosis in central nervous system malignancies: a potential role in astrocytoma progression to glioblastoma. Brain Pathol 2008; 18(2):164-71.
26. Lokker NA, Sullivan CM, Hollenbach SJ, Israel MA, Giese NA. Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors. Cancer Res 2002; 62(13):3729-35.
27. Shih AH, Holland EC. Platelet-derived growth factor (PDGF) and glial tumorigenesis. Cancer Lett 2006; 232(2):139-47.
28. Hermansson M, Nistér M, et al. Endothelial cell hyperplasia in human glioblastoma: coexpression of mRNA for platelet-derived growth factor (PDGF) B chain and PDGF receptor suggests autocrine growth stimulation. Proc Natl Acad Sci USA 1988; 85(20):7748-52.
29. OgdenAT, HorganD, Waziri A, Anderson D, et al. Defective receptor expression and dendritic cell differentiation of monocytes in glioblastomas. Neurosurgery 2006; 59(4):902-9; discussion 909-10.
30. Burim RV, Teixeira SA, Colli BO, et al. ICAM-1 (Lys469Glu) and PECAM-1 (Leu125Val) polymorphisms in diffuse astrocytomas. Clin Exp Med 2009;9(2):157-63.
31. Smith D, ShimamuraT, Barbera S, Bejcek BE. NF-kappaB controls growth of glioblastomas/astrocytomas. Mol Cell Biochem 2007; 307(1-2):141-7.
32. Ohga E, Matsuse T. The relationship between adhesion molecules and hypoxia. Nihon Rinsho 2000; 58(8):1587-91.
33. Lin CC, Lee CW, Chu TH, et al. Transactivation of Src, PDGF receptor, and Akt is involved in IL-1beta-inducedICAM-1 expression in A549 cells. J Cell Physiol 2007; 211(3):771-80.
34. Pan LH, Beppu T, Kurose A, et al. Neoplastic cells and proliferating endothelial cells express connective tissue growth factor (CTGF) in glioblastoma. Neurol Res 2002; 24(7):677-83.
35. Yin D, Chen W, O'Kelly J, et al. Connective tissue growth factor associated with oncogenic activities and drug resistance in glioblastoma multiforme. Int J Cancer 2010; 127(10):2257-67.
36. Bögler O, Mikkelsen T. Angiogenesis and apoptosis in glioma: two arenas for promising new therapies. J Cell Biochem 2005; 96(1):16-24.
37. Brat DJ, Van Meir EG. Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma. Lab Invest 2004; 84(4):397-405.
38. Tsuneyoshi N, Fukudome K, Horiguchi S, et al. Expression and anticoagulant function of the endothelial cell protein C receptor (EPCR) in cancer cell lines. Thromb Haemost 2001; 85(2):356-61.
39. Bezuhly M, Cullen R, Esmon CT, et al. Role of activated protein C and its receptor in inhibition of tumor metastasis. Blood 2009; 113(14):3371-4.
40. Deane R, LaRue B, Sagare AP, Castellino FJ, Zhong Z, Zlokovic BV. Endothelial protein C receptor-assisted transport of activated proteinCacross the mouse blood-brain barrier. J Cereb Blood Flow Metab 2009; 29(1):25-33.
41. Bae JS, Kim IS, Rezaie AR. Thrombin down-regulates the TGFbeta-mediated synthesis of collagen and fibronectin by human proximal tubule epithelial cells through the EPCR-dependent activation of PAR-1. J Cell Physiol 2010; 225(1):233-9.
42. Kargiotis O, Rao JS, Kyritsis AP. Mechanisms of angiogenesis in gliomas. J Neurooncol 2006; 8(3):281-93.
43. Zisakis A, Piperi C, Themistocleous MS, et al. Comparative analysis of peripheral and localised cytokine secretion in glioblastoma patients. Cytokine 2007; 39(2):99-105.
44. Egea V, von Baumgarten L, Schichor C, et al. TNF-_ respecifies human mesenchymal stem cells to a neural fate and promotes migration toward experimental glioma. Cell Death Differ 2011; 18(5):853-63.
45. Ghosh S, Tewari R, Dixit D, Sen E. TNF induced oxidative stress dependent Akt signaling affects actin cytoskeletal organization in glioma cells. Neurochem Int 2010; 56(1):194-201.
46. Kondo S, Yin D, Takeuchi J, et al. Tumour necrosis factor-induces an increase in susceptibility of human glioblastoma U87-MG cells to natural killer cell-mediated lysis. Br J Cancer 1994; 69(4):627-32.
47. Hagemann C, Anacker J, Haas S, et al. Comparative expression pattern of Matrix-Metalloproteinases in human glioblastoma celllines and primary cultures. BMC Res Notes 2010; 3:293.
48. Das G, Shiras A, Shanmuganandam K, Shastry P. Rictor regulates MMP-9 activity and invasion through Raf-1-MEK-ERK signaling pathway in glioma cells. Mol Carcinog 2011; 50(6):412-23.
49. Erreni M, Solinas G, Brescia P, et al. Human glioblastoma tumours and neural cancer stem cells express the chemokine CX3CL1 and its receptor CX3CR1. Eur J Cancer 2010; 46(18):3383-92.
50. Jiang CG, Lv L, Liu FR, et al. Downregulation of connective tissue growth factor inhibits the growth and invasion of gastric cancer cells and attenuates peritoneal dissemination. Mol Cancer 2011;10:122.
51. Golestaneh N, Mishra TGF-_, Neuronal Stem Cells and Glioblastoma. Oncogene 2005; 24: 5722-5730.
52. Jung Y, Joo KM, Seong DH, Choi YL, Kong DS. Identification of prognostic biomarkers for glioblastomas using protein expression profiling. Int J Oncol. 2011; doi: 10.3892/ijo.2011.1302.
53. Sullivan DE, Ferris M, Nguyen H, Abboud E, Brody AR. TNFalpha induces TGF-beta1 expression in lung fibroblasts at the transcriptional level via AP-1 activation. J Cell Mol Med 2009; (8B):1866-76.
54. Zhou F, Li GY, Gao ZZ, Liu J, Liu T, Li WR, et al. The TGF-_1/Smad/CTGF Pathway and Corpus Cavernosum Fibrous-Muscular Alterations in Rats with Streptozotocin-Induced Diabetes. J Androl 2011;[Epub ahead of print].
55. Liu F, Chen HY, Huang XR, Chung AC, Zhou L, Fu P. C-reactive protein promotes diabetic kidney disease in a mouse model of type 1 diabetes. Diabetologia 2011;54(10):2713-23.